Probing the interaction of dengue virus envelope protein with heparin: Assessment of glycosaminoglycan-derived inhibitors

Journal of Medicinal Chemistry

Volumn 44, Issue 13, 2001, Pages 2178-2187

  Marks, R M ^a   Lu, H ^a   Sundaresan, R ^a   Toida, T ^b   Suzuki, A ^b   Imanari, T ^b   Hernaiz M J ^c   Linhardt, R J ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b CHIBA UNIVERSITY   (Japan)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CYCLODEXTRIN DERIVATIVE; CHONDROITIN SULFATE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; HYALURONIC ACID; LACTOBIONIC ACID; POLYANION; SUCROSE; SUCROSE OCTASULFATE; SURAMIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ARTICLE; BINDING AFFINITY; COMPETITIVE INHIBITION; DENGUE; DENGUE VIRUS; DISSOCIATION CONSTANT; DRUG ACTIVITY; DRUG EFFECT; DRUG PROTEIN BINDING; DRUG SCREENING; NONHUMAN; SPECTROSCOPY; STRUCTURE ACTIVITY RELATION; SURFACE PLASMON RESONANCE; VIRUS CELL INTERACTION; VIRUS INFECTIVITY;

ANTICOAGULANTS; ANTIVIRAL AGENTS; BINDING, COMPETITIVE; CARBOHYDRATE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DENGUE VIRUS; ESCHERICHIA COLI; GLYCOSAMINOGLYCANS; HEPARIN; HYALURONIC ACID; KINETICS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; OLIGOSACCHARIDES; PROTEIN BINDING; STRUCTURE-ACTIVITY RELATIONSHIP; SULFATES; SURFACE PLASMON RESONANCE; VIRAL ENVELOPE PROTEINS;

EID: 0035927442     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm000412i     Document Type: Article

References (21)

1. The dengue viruses
2. Introduction
3. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
4. Inhibition of the hydrolytic activity of thrombin by chitin heparinoids
5. Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation
6. Chemical and pharmacological studies on N-resulfated heparin
7. Gradient polyacrylamide gel electrophoresis for determination of the molecular weights of heparin preparations and low-molecular-weight heparin derivatives
8. Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species
9. Determination of human urinary hyaluronic acid, chondroitin sulphate and dermatan sulphate as their unsaturated disaccharides by high-performance liquid chromatography
10. Disaccharide compositional analysis of heparin and heparan sulfate using capillary zone electrophoresis
11. Demonstration of binding of dengue virus envelope protein to target cells
12. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
13. Conformational analysis of sucrose octasulfate by high resolution nuclear magnetic resonance spectroscopy
14. Pharmacodynamics of a sulfated lactobionic acid amide-derived antithrombotic agent (Aprosulate) in primates
15. Isolation and characterization of β-cyclodextrin sulfates by preparative gradient polyacrylamide gel electrophoresis, capillary electrophoresis and electrospray ionization mass spectrometry
16. Low-molecular-weight heparins and heparinoids and their use in acute or progressing ischemic stroke
17. Preparation and anticoagulant activity of fully O-sulfonated glycosaminoglycans
18. Preparation and inhibitory activity on hyaluronidase of fully O-sulfated hyaluro-oligosaccharides